February 3, 2023
Pharmalot Columnist, Senior Writer
The falling out among the ALS Association and its chapters appears to stem from a reversal in fortunes. The ALS headquarters was, for awhile, flush with cash following the Ice Bucket Challenge fundraiser in 2014.
John Blanding/The Boston Globe via AP

STAT+ | Leading ALS advocacy group roiled by infighting over money and priorities

The ALS Association was accused in a lawsuit by more than a dozen chapters of "catastrophic leadership failures."

By Ed Silverman and Andrew Joseph

STAT+ | They were the 10% left out of life-changing treatments. Now these cystic fibrosis patients may finally get help

Vertex and other companies are starting to test treatments that could help the 10 percent of patients who were unaided by "modulator" drugs.

By Andrew Joseph

STAT+ | Turkish court hands Novartis and Roche a rare win over their efforts to promote an eye treatment

The companies have consistently run afoul of authorities in other countries where regulators have issued fines.

By Ed Silverman


The FTC is finally ready take on health data leaks. The problem is bigger than GoodRx

The FTC's action against GoodRx was a first. But with the vast amounts of health data now shared online, it’ll be far from the last. 

By Mohana Ravindranath

STAT+ | Up and down the ladder: The latest comings and goings

From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry.

By Ed Silverman

More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Pharmalot? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.